PD-L1 expression level reduction enhances the recruitment of different types of immune cells, including CD4 T cells, CD8 T cells, NK cells and CD11c+ M1-matured macrophages, while decreasing regulatory T cells in the tumor microenvironment. Here, CD8A is linked to neoplasm.